Tandem Diabetes Care (NASDAQ:TNDM) traded higher on Tuesday after Citi upgraded the insulin pump maker to Neutral from Sell, citing a shift in its risk-reward setup following the company’s ...
Diabetes technology company Tandem Diabetes Care (NASDAQ:TNDM) in Q1 CY2025, with sales up 22.3% year on year to $234.4 million. The company expects the full year’s revenue to be around $1 billion, ...
Hosted on MSN
Why Tandem Diabetes (TNDM) Stock Is Up Today
Shares of diabetes technology company Tandem Diabetes Care (NASDAQ:TNDM) jumped 5% in the morning session after the company announced the publication of a study showing its automated insulin delivery ...
Tandem Diabetes Care's top-line growth hasn't been great over the past few years. If it can successfully address challenges detrimental to revenue growth, it may become an attractive stock -- even ...
Tandem Diabetes Care, Inc. TNDM is driving transformative innovation to help reduce the burden and create new possibilities for people living with diabetes. Its strong focus on overseas expansion is ...
Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a leading insulin delivery and diabetes technology company, plans to release its third quarter 2025 results after the financial markets close on Thursday, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results